Andrea B Apolo

20PUBLICATIONS
163CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Aug 16, 2025
HER2 and urothelial carcinoma: current understanding and future directions.

Daniele Raggi, Emanuele Crupi, Filippo Pederzoli

|Aug 09, 2025
Top advances of the year: Bladder cancer.

Andrea B Apolo, Saad Atiq, Andre R Kydd

|Sep 16, 2024
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.

Andrea B Apolo, Karla V Ballman, Guru Sonpavde

Pageof 4

Frequent Collaborators

5 joint publications

James L Gulley

5 joint publications

Matthew Galsky

4 joint publications

Petros Grivas

4 joint publications

Ashish M Kamat